A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19
一项评估罗培干扰素α-2b治疗中度COVID-19患者疗效和安全性的3期随机对照试验
期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-024-00992-5
Liu, Wang-Da; Feng, Po-Hao; Cheng, Chien-Yu; Chou, Chun-Liang; Lee, Chih-Hsin; Lu, Min-Chi; Liu, Po-Yu; Lee, Mei-Hui; Liao, Chun-Hsing; Chen, Mei-Chuan; Chen, Cheng-Pin; Hsu, Shang-Fu; Tzeng, Yu-Tien; Lin, Yi-Chun; Ou, Tsong-Yih; Qin, Albert; Tsai, Chan-Yen; Shih, Weichung Joe; Lee, Kang-Yun; Sheng, Wang-Huei
